BioCatalystWatch
CTXRWorkspace / CTXR / OverviewCompany library
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. (CTXR)

Featured programme · Mino-Lok®

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

Denileukin Diftitox

IL-2 receptor (CD25)

PreINDP1P2P3FilingApproved
CITI-101

PreINDP1P2P3FilingApproved

Approved / commercial

IL-2 receptor (CD25)

PreINDP1P2P3FilingApproved
Denileukin Diftitox

IL-2 receptor (CD25)

History / paused

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CTXR PR & News

PR & News

CTXR SEC archive